Alnylam Pharmaceuticals, Inc.

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

1,533

Value ($000)

544

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	544	0.0%	1,533	12/31/2025
2025 Q3	10/24/2025	711	0.0%	1,533	9/30/2025
2025 Q2	7/30/2025	500	0.0%	1,533	6/30/2025
2025 Q1	4/24/2025	371	0.0%	1,533	3/31/2025
2024 Q4	1/28/2025	424	0.0%	1,533	12/31/2024
2024 Q3	10/25/2024	526	0.0%	1,790	9/30/2024
2024 Q2	7/17/2024	476	0.0%	1,905	6/30/2024
2024 Q1	4/23/2024	278	0.0%	1,905	3/31/2024
2023 Q4	2/1/2024	329	0.0%	1,905	12/31/2023
2023 Q3	11/3/2023	308	0.0%	1,905	9/30/2023
2023 Q2	8/1/2023	373	0.0%	1,965	6/30/2023
2023 Q1	5/2/2023	394	0.0%	1,965	3/31/2023
2022 Q4	3/2/2023	467	0.0%	1,965	12/31/2022
2022 Q3	10/25/2022	393	0.0%	1,965	9/30/2022
2022 Q2	7/26/2022	287	0.0%	1,965	6/30/2022
2022 Q1	4/13/2022	331	0.0%	2,025	3/31/2022
2021 Q4	2/14/2022	343	0.0%	2,025	12/31/2021
2021 Q3	11/12/2021	382	0.0%	2,025	9/30/2021
2021 Q2	8/13/2021	346	0.0%	2,042	6/30/2021
2021 Q1	4/14/2021	289	0.0%	2,047	3/31/2021
2020 Q4	1/14/2021	263	0.0%	2,025	12/31/2020
2020 Q3	10/15/2020	295	0.0%	2,025	9/30/2020
2020 Q2	7/30/2020	300	0.0%	2,025	6/30/2020
2020 Q1	4/15/2020	220	0.0%	2,025	3/31/2020
2019 Q4	1/22/2020	233	0.0%	2,025	12/31/2019
2014 Q1	4/28/2014	1,095	0.0%	16,315	3/31/2014
2013 Q4	2/11/2014	1,156	0.0%	17,975	12/31/2013